Related Experiment Video
Updated: Jun 1, 2025
Isolation of Primary Murine Retinal Ganglion Cells RGCs by Flow Cytometry
Published on: July 5, 2017
Differentiation of primary retinal progenitor cells into retinal ganglion-like cells using low dose cytarabine
Baoqi Hu1, Sijia Zhou2, Xiou Wang2
1Department of Ophthalmology, Xi'an No.1 Hospital, the First Affiliated Hospital of Northwest University, Xi'an, Shaanxi, 710002, China; Department of Ophthalmology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China; Shaanxi Institute of Ophthalmology, Xi'an, Shaanxi, 710002, China.
Abstract:
The death of retinal ganglion cells (RGCs) is a key factor in the pathophysiology of all forms of glaucoma. RGC culture serves as a simple system for establishing and testing candidate therapies. This study aimed to explore the differentiation of primary retinal progenitor cells (RPCs) into RGC-like cells induced by low-dose cytarabine (Ara-C). RPCs were isolated from the retina of newborn rats and cultured in vitro. Different concentrations of Ara-C were added to the culture medium to induce the differentiation of RPCs into RGC-like cells. Differentiation efficiency was assessed through immunofluorescence staining and cell counting. The addition of Ara-C significantly increased the number of Brn3a/RBPMS double-positive cells. The RPC-RGCs induced displayed characteristic features of RGCs, with roughly 80.9 % ± 6.2 % of the cells positive for both TuJ1/NeuN and 77.5 % ± 4.9 % for Brn3a/RBPMS. The study demonstrates that the addition of Ara-C to primary cultures of rat RPCs can enhance their differentiation into RGC-like cells, providing a simple and rapid method for obtaining RGC-like cells with a relatively high purity. This method shows considerable promise for advancing glaucoma research and potential therapeutic strategies to restore vision after RGC loss.
Insights
Low-dose cytarabine (Ara-C) effectively induces retinal progenitor cells (RPCs) to differentiate into retinal ganglion cell (RGC)-like cells. This method offers a promising approach for glaucoma research and vision restoration therapies.
Area of Science:
- Ophthalmology
- Neuroscience
- Cell Biology
Background:
- Retinal ganglion cell (RGC) death is central to glaucoma pathophysiology.
- Developing effective RGC culture models is crucial for testing glaucoma therapies.
- Retinal progenitor cells (RPCs) offer a potential source for generating RGCs in vitro.
Purpose of the Study:
- To investigate the efficacy of low-dose cytarabine (Ara-C) in inducing differentiation of primary rat RPCs into RGC-like cells.
- To establish a simple and rapid method for generating high-purity RGC-like cells for research.
Main Methods:
- RPCs were isolated from newborn rat retinas and cultured in vitro.
- Different concentrations of Ara-C were applied to culture media to induce differentiation.
- Immunofluorescence staining and cell counting were used to assess differentiation efficiency.
Main Results:
- Ara-C treatment significantly increased the number of Brn3a/RBPMS double-positive cells.
- Induced RPC-RGCs exhibited RGC characteristics, with high percentages positive for TuJ1/NeuN (80.9%) and Brn3a/RBPMS (77.5%).
Conclusions:
- Low-dose Ara-C enhances RPC differentiation into RGC-like cells in primary cultures.
- This method provides a rapid, high-purity source of RGC-like cells for glaucoma research.
- The approach holds promise for developing therapeutic strategies for vision restoration after RGC loss.
